Work being done at Tufts is helping to advance the field of comparative oncology, which looks at how cancer behaves and is best treated in people and other species. Video: Steffan Hacker - See more at Tufts Now
The mission of the Harrington Oncology Program is to provide the highest quality care for companion animals with cancer. This is accomplished by integrating state-of-the-art diagnostic, medical, radiation therapy and surgical techniques.
The oncology service is led by board-certified specialists in medical and radiation oncology and is supported by a team of residents, dedicated technicians and staff. We work closely with a highly skilled surgery service, with expertise in surgical oncology, as well as with specialists in internal medicine and a variety of other services. This close collaboration allows us to offer options for treatment that are tailored to the individual patient, according to the tumor type, the particular health of the patient and the family's expectations. This could be either a comprehensive treatment plan that includes a combination of different therapies or a more conservative strategy focusing on palliative care.
The radiation oncology service boasts a sophisticated linear accelerator (Siemens Primus linear accelerator with 6MV photon and 6-21 MeV electron capabilities. This unit has a 56-leaf collimator that allows for intensity modulated radiation therapy). This is only one of a few such units in operation in veterinary medical establishments. Strontium plesiotherapy is also available.
The Harrington Oncology Program is recognized nationally as a leader in the field. The members of the service are engaged in ongoing research into the causes, biology and treatment of cancer, including environmental risk factors for cancer and novel cancer therapies.